For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at […]
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and […]